As expected, treatment with decitabine led to a decrease of CTLA4 methylation and an increase of CTLA4 mRNA and CTLA-4 protein expression, indicating an epigenetic regulation of CTLA4 via DNA methylation in HNSCC. This evidence concerns the gene CTLA4 and head and neck squamous cell carcinoma.